FDA Approved: YESINTEK — Supplemental Application (Biocon Biologics Inc.)

View source ↗

Summary

The FDA approved a supplemental application for YESINTEK (ustekinumab) from Biocon Biologics Inc. The action relates to the ustekinumab biosimilar's regulatory …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• YESINTEK (USTEKINUMAB)

Snippet

SUPPL AP for YESINTEK (USTEKINUMAB)